AGIO Historical Earnings image   This AGIO historical earnings page last updated 8/8/2022
AGIO Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20220.01B
Q1 20225/5/20220.00B
Q4 20212/24/2022NA
Q3 202111/3/2021NA
Q2 20217/29/2021NA
Q1 20214/29/2021NA
Q4 20202/25/20210.04B
Q3 202011/5/20200.03B
Q2 20207/30/20200.04B
Q1 20204/30/20200.09B
Q4 20192/13/20200.04B
Q3 201910/31/20190.03B
Q2 20198/1/20190.03B
Q1 20195/2/20190.03B
Q4 20182/14/201930.01M
Q3 201811/1/201815.20M
Q2 20188/2/201840.41M
Q1 20185/4/20188.76M
Q4 20172/14/20189.80M
Q3 201711/1/201711.36M
Q2 20178/8/201711.35M
Q1 20175/4/201710.51M
Q4 20162/16/201722.65M
Q3 201611/3/20168.98M
Q2 20168/4/20166.98M
Q1 20165/4/201631.28M
Q4 20152/18/20166.22M
Q3 201511/5/20155.48M
Q2 20158/6/201513.22M
Q1 20155/7/201534.20M
Q4 20142/17/201514.64M
Q3 201411/7/201433.90M
Q2 20148/7/20148.40M
Q1 20145/8/20148.41M
Q4 20133/6/20146.74M
Q3 20139/30/20136.27B
Q2 20136/30/20136.27B
Q1 20133/31/20136.27B
AGIO Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/4/2022-1.680
Q1 20225/5/2022-1.740
Q4 20212/24/2022-1.740
Q3 202111/3/2021-1.560
Q2 20217/29/2021-1.440
Q1 20214/29/2021-1.310
Q4 20202/25/2021-1.410
Q3 202011/5/2020-1.430
Q2 20207/30/2020-1.310
Q1 20204/30/2020-0.590
Q4 20192/13/2020-1.600
Q3 201910/31/2019-1.810
Q2 20198/1/2019-1.870
Q1 20195/2/2019-1.59
Q4 20182/14/2019-1.58
Q3 201811/1/2018-1.63
Q2 20188/2/2018-1.19
Q1 20185/4/2018-1.63
Q4 20172/14/2018-1.81
Q3 201711/1/2017-1.59
Q2 20178/8/2017-1.78
Q1 20175/4/2017-1.56
Q4 20162/16/2017-1.34
Q3 201611/3/2016-1.63
Q2 20168/4/2016-1.47
Q1 20165/4/2016-0.61
Q4 20152/18/2016-1.08
Q3 201511/5/2015-1.07
Q2 20158/6/2015-0.85
Q1 20155/7/2015-0.13
Q4 20142/17/2015-0.76
Q3 201411/7/20140.1
Q2 20148/7/2014-0.54
Q1 20145/8/2014-0.39
Q4 20133/6/2014-0.4
Q3 20139/30/20133.01
Q2 20136/30/2013-2.8
Q1 20133/31/2013-2.47
Quotes delayed 20 minutes

Email EnvelopeFree AGIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Agios Pharmaceuticals (AGIO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AGL Historical Earnings
AGLE Historical Earnings
AGRX Historical Earnings
AGTC Historical Earnings
AGTI Historical Earnings
AHCO Historical Earnings
AHPI Historical Earnings
AIKI Historical Earnings
AKBA Historical Earnings
AKRO Historical Earnings
What was the record high AGIO historical earnings result?
In terms of earnings or revenue, what is the best AGIO historical earnings result that Agios Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest AGIO historical earnings result was set in Q3 2013, when Agios Pharmaceuticals posted results of 3.01/share. The most successful revenue quarter within our data set was Q3 2013 when Agios Pharmaceuticals reported revenue of 6.27B.

What was the lowest Agios Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest AGIO has reported, and when?

✔️Accepted answer: Within our data set, the lowest AGIO historical earnings result was set in Q2 2013, when Agios Pharmaceuticals posted results of -2.8/share. The smallest revenue quarter within our data set was Q4 2021 when Agios Pharmaceuticals reported revenue of NA.

On this page we presented the AGIO historical earnings date information for Agios Pharmaceuticals. Reviewing that AGIO Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2013, when AGIO posted gaap of 3.01/share. Meanwhile the lowest AGIO historical earnings result was in Q2 2013, when AGIO posted gaap of -2.8/share. Moving to Agios Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2013 when AGIO reported 6.27B in revenue, while the smallest revenue quarter was Q4 2021 when AGIO reported NA in revenue.

For self directed investors doing their due diligence on AGIO or any other given stock, their research can benefit from looking into all of the Agios Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Agios Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for AGIO. Thanks for visiting, and the next time you need to research AGIO historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: TBNK YTD Return, Institutional Holders of GLDS, Top Ten Hedge Funds Holding ARIZ.

 

AGIO Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.